Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biosimilar”

278 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 278 results

Not applicableUnknownNCT04644406
What this trial is testing

PETRA: PErtuzumab and Trastuzumab Biosimilars Real Life Association for the First Line Treatment of HER2-positive Metastatic Breast Cancer, an Observational Prospective Multicenter Study

Who this might be right for
HER-2 Positive Breast Cancer
Hospices Civils de Lyon 200
Large-scale testing (Phase 3)Study completedNCT01891864
What this trial is testing

Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Etanercept (GP2015) and Enbrel

Who this might be right for
Chronic Stable Plaque Psoriasis
Sandoz 531
Not applicableUnknownNCT05369013
What this trial is testing

Study and Follow-up of the Clinical Effectiveness and Comparative Safety of Biosimilar Teriparatide in the Management of Postmenopausal or Senile.

Who this might be right for
Osteoporosis
STADA, Spain 188
Large-scale testing (Phase 3)WithdrawnNCT03811418
What this trial is testing

Compare Pertuzumab + Trastuzumab + Vinorelbine vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-positive Metastatic Breast Cancer

Who this might be right for
Advanced Breast CancerHER2-positive Breast Cancer
iOMEDICO AG
Large-scale testing (Phase 3)Study completedNCT04967508
What this trial is testing

Compare SB17 (Proposed Ustekinumab Biosimilar) to Stelara® in Subject With Moderate to Severe Plaque Psoriasis

Who this might be right for
PsoriasisModerate to Severe Plaque Psoriasis
Samsung Bioepis Co., Ltd. 503
Large-scale testing (Phase 3)Study completedNCT06475508
What this trial is testing

Comparison of Complarate® (Tocilizumab Biosimilar) and Actemra® in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
AO GENERIUM 465
Large-scale testing (Phase 3)Active Not RecruitingNCT06847724
What this trial is testing

Comparative PK, PD, Efficacy, and Safety Assessment of the Proposed Ocrelizumab Biosimilar CYB704 and Ocrevus in Participants With Relapsing Multiple Sclerosis

Who this might be right for
Relapsing Multiple Sclerosis
Sandoz 183
Large-scale testing (Phase 3)Study completedNCT03805100
What this trial is testing

Comparing the Efficacy and Safety of Biosimilar Candidate Xlucane Versus Lucentis® in Patients With nAMD

Who this might be right for
Macular Degeneration
Xbrane Biopharma AB 582
Early research (Phase 1)Study completedNCT04015232
What this trial is testing

Comparative Immunogenicity Study of Multiple Doses of Proposed Pegfilgrastim Biosimilar, INTP5 of Intas Pharmaceuticals Ltd., India Against Neulasta of Amgen Inc., USA in Healthy, Adult Human Subjects.

Who this might be right for
ImmunogenicityHealthy Volunteers
Intas Pharmaceuticals, Ltd. 200
Early research (Phase 1)Study completedNCT03242239
What this trial is testing

A Comparing Study Between ALT02(Trastuzumab Biosimilar) and Herceptin® in Healthy Subjects

Who this might be right for
Healthy
Alteogen, Inc. 105
Not applicableUnknownNCT02341547
What this trial is testing

Effectiveness of a Biosimilar Epoetin Alfa in Stable 'End Stage Renal Failure'

Who this might be right for
End Stage Renal FailureAnaemia
Penang Hospital, Malaysia 44
Large-scale testing (Phase 3)Study completedNCT04934072
What this trial is testing

Evaluate the Efficacy, Pharmacodynamics, Safety, and Immunogenicity of FKS518 in Postmenopausal Women With Osteoporosis

Who this might be right for
Postmenopausal Osteoporosis
Fresenius Kabi SwissBioSim GmbH 553
Not applicableLooking for participantsNCT07077681
What this trial is testing

Evaluation of the Acceptability and Therapeutic Maintenance After Substitution of Ustekinumab With a Biosimilar

Who this might be right for
Crohn Disease (CD)
EG Labo 246
Testing effectiveness (Phase 2)Ended earlyNCT03645876
What this trial is testing

SHR-1210 in Combination With BP102 and XELOX in Patient With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Jiangsu HengRui Medicine Co., Ltd. 12
Not applicableUnknownNCT04422171
What this trial is testing

A 12-month Real Life Study of IBD Patients Switched From Adalimumab Originator Humira® to One of Its Biosimilar

Who this might be right for
IBD Patients, Originator Treatment, Biosimilar, Switch Back
University Hospital, Grenoble 400
Large-scale testing (Phase 3)Ended earlyNCT06038539
What this trial is testing

Efficacy and Safety of the Proposed Biosimilar Pertuzumab (PERT-IJS) Versus EU-Perjeta® Along With Trastuzumab and Chemotherapy (Carboplatin and Docetaxel) as Neoadjuvant Treatment in Chemotherapy naïve Patients With Early Stage or Locally Advanced HR Negative and HER2 Positive Breast Cancer

Who this might be right for
HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients
Biocon Biologics UK Ltd 55
Large-scale testing (Phase 3)Ended earlyNCT06587451
What this trial is testing

Integrated Pharmacokinetics (PK)/Efficacy, Safety, and Immunogenicity Study to Demonstrate Similarity of JPB898, a Proposed Biosimilar to Nivolumab, to Opdivo® in Combination With Yervoy®

Who this might be right for
Melanoma
Sandoz 52
Not applicableUnknownNCT02066272
What this trial is testing

Safety of Anti-tumor Necrosis Factor (TNF) Monoclonal Antibodies in Inflammatory Bowel Disease

Who this might be right for
Inflammatory Bowel DiseaseUlcerative ColitisCrohn's Disease+1 more
Maria Sklodowska-Curie National Research Institute of Oncology 400
Not applicableLooking for participantsNCT07746583
What this trial is testing

Guselkumab Given After Ustekinumab in Participants With Moderate to Severe Psoriasis in Routine Clinical Practice

Who this might be right for
Psoriasis
Janssen-Cilag Kft. 100
Not applicableLooking for participantsNCT07244614
What this trial is testing

Ustekinumab in BEhçet's Syndrome STudy

Who this might be right for
Behçet's Syndrome (BS)
Groupe français d'étude des Maladies Inflammatoires de loeil 208
Next Page